{"schema_version":"secwatch.filing_event.v1","accession":"0001829126-25-008357","form_type":"8-K","ticker":"ZEOX","cik":"0001557376","company_name":"Zeo ScientifiX, Inc.","filed_at":"2025-10-23T23:59:59+00:00","discovered_at":"2026-05-14T18:02:39.731021+00:00","generated_at":"2026-05-17T02:29:57.904421+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"ZEO ScientifiX positioned for Florida stem cell market growth after SB 1768 enactment","bullets":["Florida SB 1768, effective July 1, 2025, allows physicians to administer non-FDA-approved stem cell therapies for orthopedic, wound care, and pain under cGMP.","ZEO expects revenue growth from increased physician demand, patient awareness, and medical tourism to Florida.","Company launched IRB-approved clinical study (PPX™) for musculoskeletal joint pathologies, targeting up to 350 patients; 5 clinics enrolled, 7 patients to date.","ZEO evaluating lab expansion at Nova Southeastern University for additional clean rooms and research space.","New law enables collection of real-world safety/outcome data, potentially lowering risks for future FDA submissions."],"urls":{"canonical":"https://secwatch.observer/filing/0001829126-25-008357","json":"https://secwatch.observer/filing/0001829126-25-008357.json","markdown":"https://secwatch.observer/filing/0001829126-25-008357.md","text":"https://secwatch.observer/filing/0001829126-25-008357.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1557376/000182912625008357/0001829126-25-008357-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1557376/000182912625008357/zeoscientifix_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T02:29:57.904421+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}